These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23671251)

  • 1. Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience.
    Ashina M; Hansen JM; Olesen J
    Cephalalgia; 2013 Jun; 33(8):540-53. PubMed ID: 23671251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological migraine provocation: a human model of migraine.
    Ashina M; Hansen JM
    Handb Clin Neurol; 2010; 97():773-9. PubMed ID: 20816469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have we learnt from triggering migraine?
    Schytz HW; Schoonman GG; Ashina M
    Curr Opin Neurol; 2010 Jun; 23(3):259-65. PubMed ID: 20173638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroglycerin provocation in normal subjects is not a useful human migraine model?
    Tvedskov JF; Iversen HK; Olesen J; Tfelt-Hansen P
    Cephalalgia; 2010 Aug; 30(8):928-32. PubMed ID: 19740120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding new drug targets for the treatment of migraine attacks.
    Olesen J; Tfelt-Hansen P; Ashina M
    Cephalalgia; 2009 Sep; 29(9):909-20. PubMed ID: 19250288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a reliable animal model of migraine.
    Olesen J; Jansen-Olesen I
    Cephalalgia; 2012 May; 32(7):578-80. PubMed ID: 22451494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: recent findings in animals].
    Mick G
    Pathol Biol (Paris); 2000 Sep; 48(7):593-607. PubMed ID: 11072637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human migraine models.
    Iversen HK
    Cephalalgia; 2001 Sep; 21(7):781-5. PubMed ID: 11595013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental migraine models and their relevance in migraine therapy.
    Arulmani U; Gupta S; VanDenBrink AM; Centurión D; Villalón CM; Saxena PR
    Cephalalgia; 2006 Jun; 26(6):642-59. PubMed ID: 16686903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of carbachol and PACAP38 in a human model of migraine.
    Schytz HW
    Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back.
    Demartini C; Greco R; Zanaboni AM; Sances G; De Icco R; Borsook D; Tassorelli C
    Prog Neurobiol; 2019 Jun; 177():15-32. PubMed ID: 30771365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide theory of migraine.
    Thomsen LL; Olesen J
    Clin Neurosci; 1998; 5(1):28-33. PubMed ID: 9523055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and proposal for optimization of neurophysiological tests in migraine: part 2--neuroimaging and the nitroglycerin test.
    Magis D; Bendtsen L; Goadsby PJ; May A; Sánchez del Rio M; Sandór PS; Kaube H; Sandrini G; Schoonman GG; Schoenen J; Afridi S;
    Cephalalgia; 2007 Dec; 27(12):1339-59. PubMed ID: 17970767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.
    Tvedskov JF; Iversen HK; Olesen J
    Cephalalgia; 2004 Oct; 24(10):875-82. PubMed ID: 15377319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Headache and non-headache symptoms provoked by nitroglycerin in migraineurs: A human pharmacological triggering study.
    Karsan N; Bose PR; Thompson C; Newman J; Goadsby PJ
    Cephalalgia; 2020 Jul; 40(8):828-841. PubMed ID: 32164428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review.
    Olesen J
    J Headache Pain; 2024 Jun; 25(1):105. PubMed ID: 38902612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors.
    Gupta S; Villalón CM
    Pharmacol Ther; 2010 Oct; 128(1):170-90. PubMed ID: 20655327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.